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Abstract
Amyloid b-peptide (Ab) is directly linked to Alzheimer’s disease (AD). In its monomeric form, Ab aggregates to produce
fibrils and a range of oligomers, the latter being the most neurotoxic. Dysregulation of Ca
2+ homeostasis in aging brains and
in neurodegenerative disorders plays a crucial role in numerous processes and contributes to cell dysfunction and death.
Here we postulated that calcium may enable or accelerate the aggregation of Ab. We compared the aggregation pattern of
Ab(1–40) and that of Ab(1–40)E22G, an amyloid peptide carrying the Arctic mutation that causes early onset of the disease.
We found that in the presence of Ca
2+,A b(1–40) preferentially formed oligomers similar to those formed by Ab(1–40)E22G
with or without added Ca
2+, whereas in the absence of added Ca
2+ the Ab(1–40) aggregated to form fibrils. Morphological
similarities of the oligomers were confirmed by contact mode atomic force microscopy imaging. The distribution of
oligomeric and fibrillar species in different samples was detected by gel electrophoresis and Western blot analysis, the
results of which were further supported by thioflavin T fluorescence experiments. In the samples without Ca
2+, Fourier
transform infrared spectroscopy revealed conversion of oligomers from an anti-parallel b-sheet to the parallel b-sheet
conformation characteristic of fibrils. Overall, these results led us to conclude that calcium ions stimulate the formation of
oligomers of Ab(1–40), that have been implicated in the pathogenesis of AD.
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Introduction
Alzheimer’s disease (AD) is a progressive neurodegenerative
disorder that affects nearly 2% of the population in industrialized
countries. AD is the most common form of dementia and is
characterized by brain cell destruction, memory loss, and
deterioration of cognitive and behavioral processes severe enough
to affect work, lifelong hobbies, and social life. Symptoms worsen
over time and the disease is fatal.
For many years, the pathologic hallmark of AD was attributed
to the continuous accumulation of amyloid b-peptide (Ab) fibrils
into plaques. Their toxic effects on synaptic connections and
neurons were explained by the amyloid cascade hypothesis [1].
However, experiments aimed at establishing a direct causal
relationship between Ab deposition and the neurodegeneration
that underlies AD dementia failed [2,3]. This apparent discrep-
ancy between plaque burden and neuronal dysfunction has been
described in transgenic mouse models of AD [4,5]. Recent theories
that apparently resolve this inconsistency refer to small soluble
oligomeric or protofibrillar assemblies of Ab [6,7], shown to be
toxic to neurons and their vital interconnections [8–10]. Results of
studies that focused on the electrophysiological impact of Ab
oligomers suggested that the underlying memory loss is caused by
rapid inhibition of long-term potentiation (LTP)—a classical
model for synaptic plasticity and memory mechanisms [11]—by
oligomers [12–14], which might explain, at least in part, the mild
cognitive impairment observed in the early stages of AD [9].
Ab peptide is a product of the proteolytic cleavage of the
amyloid precursor protein (APP). Although Ab peptides may vary
in length from 38 to 43 amino acids, the two main alloforms in the
brain are Ab(1–40) and Ab(1–42). Both peptides have been found
in amyloid plaques [15–17] and shown to form oligomers and
protofibrils [18]. Post-mortem analysis in human subjects disclosed
that Ab(1–40) rather than Ab(1–42), whether in soluble or in
insoluble form, discriminated more readily between AD patients
and high pathology controls [8]. In addition to sporadic cases of
AD, several familial Alzheimer’s disease (FAD) mutations have
been discovered and studied over the years. Most of these
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processing. A new mutation within the APP sequence Ab(E22G),
found to cause AD in Swedish families, was reported in 2001 by
Nilsberth et al., who named it the Arctic mutation. Those authors
observed that carriers of this mutation showed decreased amounts
of Ab(1–42) and Ab(1–40) in the plasma, and demonstrated that
Ab(1–40)E22G forms protofibrils much faster and more abun-
dantly than the wild-type Ab, whereas the rate of fibrillization
remained the same [19]. Later studies suggested that the clinical
and pathological features of patients with the Arctic mutation are
attributable to increased generation of Ab intermediates formed
early in fibrillogenesis, as well as their greater stability [20].
Moreover, Ab(1–40)E22G was shown to rapidly induce neuro-
toxicity, and that this correlated with the formation of small pre-
fibrillar assemblies, including protofibrils [21]. Clinical and
pathological features of FAD are indistinguishable from those of
sporadic cases, but disease onset occurs at a much younger age in
patients with the Arctic mutation [19,22].
Research has so far failed to establish any unique primary
mechanism underlying the Ab aggregation followed by neuronal
degeneration and death in patients with AD. Rather, it seems
likely that numerous processes participate both in Ab aggregation
and in the ultimate development of the disease. One of the many
hypotheses put forward to account for the etiology of AD argues
that a central role in AD pathology is played by dysregulation of
calcium homeostasis [23–25]. The idea that altered calcium
homeostasis might serve as a trigger in the development of AD was
first formulated in 1982 and later revised by Khachaturian [26].
The principal risk factor for AD is advanced age. In sporadic
cases, the first manifestations of the disease symptoms occur
towards the seventh decade of life. Neuronal activation is usually
associated with an increase in intracellular Ca
2+ concentration
([Ca
2+]i), while the source of the Ca
2+ ions can be either
extracellular or intracellular. Age-related alterations in Ca
2+-
specific regulatory systems in neurons include increased amounts
of intracellular Ca
2+, enhanced Ca
2+ influx through voltage-
dependent Ca
2+ channels, impaired mitochondrial ability to buffer
or cycle Ca
2+ [27], and perturbed Ca
2+ regulation in ryanodine
(Ry)-sensitive and Ins(1,4,5)P3-sensitive Ca
2+ stores [28].
Numerous studies have implicated Ca
2+ dysfunction in AD,
demonstrating the bidirectional relationship between Ca
2+ signal-
ing and the amyloidogenic pathway [29,30]. On the one hand,
certain alterations in Ca
2+ signaling are common to both sporadic
and familial cases of AD [31,32]. Direct measurements of [Ca
2+]i
show that cells exposed to Ab exhibit disruption in calcium
homeostasis [33,34], which may in turn cause a variety of
secondary effects such as activation of cellular enzymes, induction
of apoptosis, and cytoskeletal modifications [35,36]. Ab can
reportedly trigger Ca
2+ release from endoplasmic reticulum (ER)
stores via interaction with IP3 and Ry receptors [37,38], as well as
an increase in calcium influx via the NMDA receptors [39,40].
Formation of cation-selective channels by Ab in bilayer mem-
branes and in living cells [41,42] further enhances the ability of
this peptide to alter cytosolic Ca
2+ homeostasis. On the other
hand, changes in the amounts and dynamics of Ca
2+ alter the
metabolism and production of Ab [30]. Influx of Ca
2+ through
calcium channels of the plasma membrane or through calcium
release from ER stores increases Ab generation [43]. An increase
in cytosolic Ca
2+ concentration, moreover, was shown to induce
transient phosphorylation of APP and tau, leading to an increased
production of intracellular Ab [44].
In this study we used gel electrophoresis and Western blot
analysis, thioflavine T (ThT) fluorescence, Fourier transform
infrared spectroscopy (FTIR), and atomic force microscopy
imaging (AFM) to compare the aggregation of Ab(1–40) and
Ab(1–40)E22G, in order to study the structural and morphological
similarities of the species—oligomeric or fibrillar—formed by both
peptides in the presence and in the absence of added Ca
2+.W e
postulated that when calcium dysregulation takes place under
conditions of normal aging, it may facilitate the formation of
pathogenic Ab oligomers, which in turn may intensify the Ca
2+
dyshomeostasis. The oligomeric species may then be held
accountable for mediating the neuronal injury and LTP inhibition
characteristic of AD in elderly individuals, similar to the situation
in FAD patients carrying the Arctic mutation. Detailed knowledge
of the action of Ca
2+ upstream of Ab is a prerequisite for complete
understanding of the molecular mechanism(s) responsible for the
age-related risks of Alzheimer’s disease. Because Ab plays a
fundamental part in the development and devastating progression
of AD, we believe that understanding of the formation and
properties of its toxic forms will provide a key to the
comprehension of the disease mechanism, thereby enabling us to
develop novel preventive and therapeutic approaches.
Methods
Chemicals
All chemicals were purchased from Sigma-Aldrich or Bio-Rad,
unless stated otherwise.
Peptide preparation
The amyloid b-peptides Ab(1–40) and Ab(1–40)E22G were
purchased from American Peptide Company in the form of
lyophilized powder. Prior to use, 1 mg aliquots were dissolved in
double-distilled water, sonicatedin a water bath for 1 min, and then
held in ice for 1 min. This cycle was repeated five times. The
peptide solution was then divided into 50-mg aliquots and dried
under vacuum in a ThermoSavant SpeedVac (UVS400A Universal
Vacuum System). Ab films were stored at 220uC until use.
Sample preparation
The 50- mg aliquots of lyophilized Ab peptide were hydrated at
room temperature in either 50 mM phosphate buffer pH 7.4 and
100 mM NaCl (‘‘–Ca
2+ condition’’) or 75 mM MOPS pH 7.4 and
2 mM CaCl2 (‘‘+Ca
2+ condition’’). The ‘‘2Ca
2+ condition’’ refers
to the condition where no calcium was added to the buffer.
However, contaminating calcium concentration was 2161.3 mM,
as was determined with inductively coupled plasma optical
emission spectroscopy (ICP-OES). The final concentration of the
peptide for all samples was 100 mM unless otherwise stated.
Samples were sonicated for 2 min in a water bath and incubated
at 37uC without agitation.
Thioflavin T (ThT) fluorescence measurements
The thioflavin T (Sigma-Aldrich) fluorescence assay [45] was
used to follow the aggregation profile of Ab peptides for 96 h in an
LS55 fluorimeter (Perkin Elmer Instruments). Aliquots of 10 ml
(,4 mg) of the incubated peptide solution were added to 1 ml of
50 mM glycine-NaOH buffer pH 8.5 and 5 mM ThT. The sample
was maintained at 25uC in a circulating water bath. Excitation and
emission wavelengths were 450 nm and 482 nm, respectively. The
emission spectra were collected for 500 s. The intensity of each
spectrum was then averaged over approximately 400 s, following
subtraction of the averaged (100 s) background fluorescence.
Western blot analysis
Peptide samples were diluted in a PAGE sample buffer and
separated on a 12% bis-Tris gel at 4uC for 2 h at 100 V. There
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4% SDS. Unboiled samples were loaded on the gel. The separated
bands of protein were transferred onto a nitrocellulose membrane,
which was then blocked for 1 h in 5% nonfat dry milk in Tris-
buffered saline (TBS)/Tween-20 buffer. The membrane was
incubated with a mixture of two mouse monoclonal Ab antibodies,
6E10 (1:3000) and 4G8 (1:2000) (Sigma-Aldrich). Detection was
carried out by enhanced chemiluminescence using horseradish
peroxidase-conjugated goat anti-mouse antibody (1:2000) (Boeh-
ringer Mannheim). Images were recorded and analyzed using the
ImageQuant 400 gel imager and ImageQuant TL software (GE
Healthcare).
Fourier transform infrared (FTIR) spectroscopy
Infrared spectra were recorded on an Equinox 55 infrared
spectrophotometer (Bruker Optics). The internal reflection
element was a diamond crystal (262 mm) with an aperture angle
of 45u, yielding a single internal reflection. The spectrometer was
purged continuously with dried air. Spectra were obtained from
4000 cm
21 to 800 cm
21 at a resolution of 2 cm
21. In order to
achieve a good signal-to-noise ratio, 128 scans were acquired. All
measurements were conducted at 24uC. Samples were prepared
by spreading 2 ml of peptide solution on a diamond crystal surface
and removing the excess fluid under nitrogen flow. The film was
washed three times with milliQ water, which was then removed
under nitrogen flow.
Spectral analysis
Data were processed using ‘‘Kinetics’’, a program developed in
our laboratory and running under MatLab. Briefly, spectra were
subjected to water-vapor subtraction using a reference water vapor
spectrum, and to a smoothing procedure to 4 cm
21. Spectra were
deconvoluted using the Lorentzian deconvolution function and the
Gaussian apodization function. A linear baseline was subtracted
from all spectra at 1708, 1602, and 1482 cm
21.
Atomic force microscopy (AFM)
AFM contact mode images were obtained at room temperature
with a Nanoscope IV Multimode AFM (Veeco). Fresh mica
surfaces (36 mm
2) were glued onto steel sample discs (Veeco) with
Epotek 377 (Gentec Benelux). Atomically smooth surfaces were
generated by cleaving layers with adhesive tape. Peptide solution
(100 ml; 0.1 mg/ml) was adsorbed onto bare mica surfaces for 1 h.
The mounted samples were immediately transferred into the AFM
liquid cell, while avoiding dewetting. They were then imaged with
oxide-sharpened microfabricated Si3N4 cantilevers (Microlevers,
Veeco) with minimal applied force (,500 pN). The spring
constants of the cantilevers measured by the thermal noise method
(Picoforce, Veeco) were 0.011 N/m. Images (5 mm 65 mm) were
obtained from several areas on each sample.
Results
Preferential formation of oligomeric, not fibrillar, species
by Ab(1–40) in the presence of Ca
2+
Samples of Ab(1–40) and Ab(1–40)E22G were prepared and
incubated for 96 h in either the presence or the absence of 2 mM
Ca
2+.Attimepointscorrespondingtot=0,2,4,6,24 ,72 ,an d96h,
samples were analyzed by electrophoresis in SDS-free polyacryl-
amide gel (0.1% SDS was present in the migration buffer) and
imaged by Western blotting (Fig. 1). Over time, the aggregation
pattern of Ab(1–40) showed striking differences in the presence and
in the absence of added Ca
2+ (Fig. 1A, C). Whereas after 24 h the
range of oligomeric species in the samples with and without added
Ca
2+ was almost indistinguishable, at 72 h we observed a wide
range of species in the presence of Ca
2+, but not in its absence. At
72 h and 96 h, Ab(1–40) in the presence of Ca
2+ contained
monomers and oligomers whose molecular weights ranged from
those consistent with dimers (around 8 kDa) to hexamers (Fig. 1C,
two last lanes). Additional streaks in the same lanes suggested the
presence of oligomers of even higher molecular weight, though they
were not clearly identified. In the same samples, protofibrils and
apparently some fibrils were also detectable at the top portion of the
gel. It was difficult to differentiate between these aggregates because
of the low resolution in this part of the gel and their low
electrophoretic mobility. Fibrils, because of their extremely high
molecular weight, do not penetrate into the separating part of the
polyacrylamidegel;thus,when present, theyappearassmearsinthe
stacking portion of the gel. In the absence of added Ca
2+,A b(1–40)
molecules had aggregated to such an extent that we were able to
detect only bands with low electrophoretic mobility corresponding
mainly to high-molecular-weight oligomers, protofibrils and fibrils,
located in or near the stacking part of the polyacrylamide gel
(Fig.1A, two last lanes).
In contrast to Ab(1–40), samples of Ab(1–40)E22G that were
incubated under the same conditions as the Ab(1–40) samples
showed no differences in their aggregation profiles in the presence
and absence of added Ca
2+ (Fig. 1B, D). Moreover, already at
t=0 h we observed oligomers ranging from monomers to
tetramers that were not present in Ab(1–40) samples at the same
time point. From t=24 h, we observed an increase in the
population of oligomers of low molecular weight as well as the
appearance of high-molecular-weight oligomers in Ab(1–40)E22G
samples, in both conditions. By t=72 h and t=96 h a wide range
of oligomers, including protofibrils, could be seen. These findings
clearly indicated that Ca
2+ had no influence on the ability of Ab(1–
40)E22G to aggregate as expected, with the generation mainly of
oligomers and protofibrils.
A comparison of the results obtained for the two peptides thus
clearly showed that in the presence of Ca
2+ Ab(1–40), like Ab(1–
40)E22G, aggregated to produce oligomers and protofibrils,
whereas in the ‘‘–Ca
2+’’ condition fibrils were readily formed.
The profile of oligomeric and protofibrillar species formed by
Ab(1–40) in the presence of Ca
2+, as detected by Western analysis,
was essentially the same as that of Ab(1–40)E22G in either
condition.
Ca
2+ inhibits formation of thioflavin T-positive Ab(1–40)
species but does not affect Ab(1–40)E22G
The increase in ThT fluorescence over time was used to follow
fibrillogenesis of amyloid peptides Ab(1–40) and Ab(1–40)E22G in
solution in the presence and absence of added Ca
2+. We found
that Ca
2+ inhibited the formation of ThT-positive species of Ab(1–
40), but had no effect on Ab(1–40)E22G (Fig. 2).
We performed a time-course study during 96 h of incubation
with or without Ca
2+ for both peptides. In the case of Ab(1–40),
ThT fluorescence intensity did not change in either the presence or
the absence of added Ca
2+ and remained low for the first 6 h,
demonstrating that after 6 h of incubation the predominant species
are oligomers. This result is in agreement with the reported finding
that ThT fluorescence clearly discriminates between oligomers and
fibrils of Ab [46]. After 24 h of incubation, ThT fluorescence
intensity was found to be increased significantly (about three fold) in
the absence of added Ca
2+ but only slightly in its presence. After 72
and 96 h of incubation the ThT fluorescence intensity in the
absence of added Ca
2+ increaseddramatically, reaching valuesclose
to 500 arbitrary units. Control samples with known fibrillar content
yielded similar fluorescence values (data not shown), leading us to
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conclusion is supported by a number of studies in which the
characteristic fluorescence exhibited by ThT was attributed to the
binding of ThT molecules within a cavity that was present in some
proteins and amyloid fibrils, but not in others [47,48]. After 96 h of
incubation of Ab(1–40) in the presence of Ca
2+, fluorescence
intensityvaluesremained lowandwereattributedtothe existenceof
only a small population of ThT-positive species.
By contrast Ab(1–40)E22G, both with and without Ca
2+,
exhibited stable and relatively low ThT fluorescence intensity over
the course of 96 h (Fig. 2), implying either that the aggregation
process is significantly slower than for Ab(1–40) or that Ab(1–
40)E22G has a relatively high propensity to form oligomers rather
than fibrils. A high tendency of Ab(1–40)E22G to form oligomers
and protofibrils has already been demonstrated in several studies
[49,19,20]. Moreover, it was suggested that this characteristic
behavior may be responsible for the marked toxicity of Ab(1–
40)E22G [21]. Individuals carrying the Arctic mutation are known
to be prone to development of AD early in life [19], possibly
because of the formation of oligomers and protofibrils, considered
to be more toxic aggregates of Ab peptide than fibrils.
Oligomers formed by Ab(1–40) in the presence of Ca
2+
and oligomers formed by Ab(1–40)E22G demonstrate
similar secondary structures
Secondary structures of Ab aggregates are known to possess
high b-sheet content. Using ATR2FTIR spectroscopy, our group
Figure 1. Aggregation profiles of Ab(1–40) and Ab(1–40)E22G by Western blot analysis. Aggregation profiles of Ab(1–40) and Ab(1–
40)E22G during 96 h of incubation in the presence or absence of added Ca
2+ were followed using Western blot analysis. Samples were separated
using gel electrophoresis on a 12% bis-Tris gel. For each condition, samples were taken at t=0, 2, 4, 6, 24, 72, and 96 h. Following the loading of 1 mg
of protein sample into each lane, the membrane was probed with a mixture of monoclonal antibodies 6E10 and 4G8 that recognize residues 1–17
and 17–24, respectively. Panels A and B are representative Western blots of Ab(1–40) and Ab(1–40)E22G in phosphate buffer (‘‘–Ca
2+ condition’’),
respectively. Panels C and D are representative Western blots of Ab(1–40) and Ab(1–40)E22G in 2 mM Ca
2+ (‘‘+Ca
2+ condition’’), respectively. At least
four separate experiments were carried out to confirm these results. All images were taken from a single 96-h experimental procedure.
doi:10.1371/journal.pone.0018250.g001
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of Ab is an anti-parallel b-sheet conformation, whereas parallel b-
sheet conformation is indicative of the presence of Ab fibrils
[50,51]. Working with Ab(1–42) and Ab(1– 40), they demonstrat-
ed that in anti-parallel b-sheet structures the amide I region
displays two typical components: the major component has an
average spectral wavenumber at ,1630 cm
21 while the minor
component, about five fold weaker than the major one, is
characterized by an average wavenumber at ,1695 cm
21. For
parallel b-sheet structures the amide I region displays only the
major component of ,1630 cm
21. The intensity ratio of 1695/
1630 was suggested to be proportional to the percentage of anti-
parallel b-strands arranged in a b-sheet [52].
Using ATR2FTIR, we studied the aggregation patterns of
Ab(1–40) and Ab(1–40)E22G and followed the evolution of 1630-
cm
21 and 1695-cm
21 peaks to assess the presence of oligomers or
fibrils as a function of incubation time, based on discrimination of
a b-sheet conformation. Figure 3 summarizes the results observed
for each of these amyloid peptides in the presence and in the
absence of added Ca
2+. For all conditions evaluated, during the
first 48 h we observed two characteristic features: one peak at
,1695 cm
21 and another at ,1630 cm
21 (Fig. 3, panels A–D).
The presence of a peak at ,1695 cm
21 in the infrared spectrum,
in addition to a peak at ,1630 cm
21, is characteristic of an anti-
parallel b-sheet conformation, indicative of species structurally
different from fibrils [51,50]. However, for Ab(1–40) in the
absence of added Ca
2+ we observed a significant decrease in the
,1695 cm
21 peak at t=48 h (Fig. 3A) and a shift towards lower
wavenumbers and narrowing of the ,1630 cm
21 peak. This shift
(from 1633 cm
21 to 1629 cm
21) and narrowing were also
detectable to some extent at earlier time points. This specific
feature indicated formation of stable and/or long b-strands and
strong hydrogen bonds, as would be expected for a stable fibrillar
structure [53]. Given that the ratio of 1695/1630 is proportional
to the percentage of anti-parallel arrangement of b-strands [52],
we used this ratio to estimate the degree of structural change in our
samples. For Ab(1–40) in the ‘‘–Ca
2+ condition’’ the 1695/1630
ratio decreased dramatically from 0.32 at t=0 h to 0.08 at
t=96 h, meaning that there was four times less anti-parallel b-
sheet structure after 96 h of incubation in the absence of added
Ca
2+. This pattern of decrease in the amount of anti-parallel b-
strands in a b-sheet points to the formation of fibrillar assemblies
from oligomers initially present in the sample. This result
complements the outcome of the PAGE analysis and the ThT
fluorescence experiments, where after the first 24 h we detected
mainly oligomers whose binding affinity for ThT was low, whereas
at t=96 h the species observed by PAGE were mainly of high
molecular weight (including fibrils), which were highly ThT
positive. This result for Ab(1–40) in phosphate buffer portrayed a
dynamic process of fibrillization of the Ab(1–40) peptide in vitro,
starting with monomers and dimers, which over time were
converted into fibrils. It was interesting to note that at t=72 h and
t=96 h, no monomers, dimers, or other low-molecular-weight
oligomers were visible on Western blots, indicating abundant
conversion to fibrils.
The behavior of Ab(1–40) samples in the presence of Ca
2+
differed from their behavior in the absence of added Ca
2+.
Throughout the duration of the experiment with Ab(1–40) in the
presence of Ca
2+ we always observed the two characteristic peaks
at ,1695 cm
21 and ,1630 cm
21 (Fig. 2, panel C). Despite the
slight decrease observed over time in the intensity of the
,1695 cm
21 peak, no significant narrowing of the peak width
at ,1630 cm
21 was detected.
An interesting observation was that this spectral behavior of
Ab(1–40) in the presence of Ca
2+ had the same features as that of
Ab(1–40)E22G in either the presence or the absence of Ca
2+.
Under both conditions, the peaks exhibited by Ab(1–40)E22G at
,1695 cm
21 and at ,1630 cm
21 throughout the 96-h time
period were characteristic of an anti-parallel b-sheet conformation
(Fig. 3, panels C, B, D), and the ratio between the peaks changed
only slightly, mainly after the first 2 h. In addition, no narrowing
of the peak at ,1630 cm
21 was detected. This finding, obtained
by ATR2FTIR, showed good correlation with the results we
obtained by PAGE analysis and in our ThT fluorescence
experiments, all of which pointed—as expected, and in line with
the published data [20,21]—to the formation of a wide range of
oligomers and possibly also protofibrils by Ab(1–40)E22G. The
similarity in aggregation patterns of Ab(1–40) in the ‘‘+Ca
2+
condition’’ and of Ab(1–40)E22G under both conditions, as
observed here by three independent techniques, raises a
fundamental question concerning a possible change in the
mechanism of Ab(1–40) aggregation when Ca
2+ is present. It
seems that calcium ions promote the preferential formation of
oligomers and protofibrils, diverting the otherwise favored
fibrillogenesis pathway.
Formation of Ab(1–40) species morphologically similar to
the species formed by Ab(1–40)E22G in the presence of
Ca
2+
Next we examined whether the oligomers formed by Ab(1–40)
in the presence of Ca
2+ and the oligomers formed by Ab(1–
40)E22G in the presence and in the absence of added Ca
2+ share
morphological similarities. Using contact mode AFM, we followed
oligomerization and fibrillogenesis of Ab(1–40) and of Ab(1–
40)E22G, in all cases in the presence and absence of added Ca
2+,
at three time points: t=0, 6, and 72 h (Fig. 4). These times were
chosen because most of the differences detected by Western blot
analysis, ThT fluorescence, and ATR2FTIR spectroscopy were
observed after 0, 6, and 72 h of incubation.
At t=0 h, samples of Ab(1–40) and of Ab(1–40)E22G, in all
cases both in the presence and in the absence of added Ca
2+,
Figure 2. Oligomers and fibrils formation differentiated by ThT
fluorescence. ThT fluorescence intensity was monitored to follow
fibrillogenesis of Ab(1–40) and Ab(1–40)E22G in the presence and in the
absence of 2 mM Ca
2+. Black bars, Ab(1–40) in phosphate buffer (‘‘–Ca
2+
condition’’); light grey bars, Ab(1–40) in 2 mM CaCl2; dark grey bars,
Ab(1–40)E22G in phosphate buffer; light blue bars, Ab(1–40)E22G in
CaCl2. Shown are averages of values obtained in four independent
experiments; error bars indicating the standard error of the average.
doi:10.1371/journal.pone.0018250.g002
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panels A, D, G, J), in agreement with previously reported data
[54]. The height of the spherical aggregates was 2.860.3 nm
(n=51). Although some linear aggregates were detected in Ab(1–
40) samples in the absence of added Ca
2+ (Fig. 4A), most of the
population consisted of globular particles. Since no contribution
was seen from the linear aggregates when these samples were
tested with other techniques, it seems reasonable to assume that
only an insignificant percentage of the peptide was present in the
linear aggregate form (perhaps structurally different from fibrils) at
the initial stages of incubation. Notably, this population was
observed only in the Ab(1–40) samples lacking Ca
2+, even though
all the samples received identical treatment.
A second batch of samples was imaged at t=6 h. As expected,
no differences in aggregate morphology were noticed between the
Ab(1–40) samples in the presence of Ca
2+ and the Ab(1–40)E22G
samples in the presence or absence of added Ca
2+ (Fig. 4E, H, K).
All of the particles appeared to be globular, though somewhat
larger than at t=0 h (height 3.360.5 nm, n=20). Evolution of the
species was observed only with Ab(1–40) in the absence of added
Ca
2+. In this case there was clear evidence of fibrillization,
resulting in a large amount of string-like aggregates and a long,
fibril-like species (Fig.4B). Although comparable in length
(9506460 nm, n=20) to previously reported fibril lengths [54],
they were too thin to be categorized as fibrils. The string-like
structures had become more abundant, and the fraction of
spherical particles that remained was small (Fig. 4B).
The most striking differences were those observed between
samples imaged at t=72 h. The Ab(1–40) samples without Ca
2+
exhibited well-organized fibrils (Fig. 4C) whose dimensions (height
8.460.5 nm, n=13; width 124615 nm, n=12; length 160.6 mm,
n=67) mostly correlated with those previously published for Ab(1–
40) [53]. When Ab(1–40) was incubated in the presence of Ca
2+
the resulting aggregates were not fibrillar, but rather spherical
(height, 2.660.4 nm; n=24) and (mostly) curvilinear (Fig. 4F)
(height 3.060.5 nm; n=28; length 250673 nm; n=40), which
previous authors have referred to as oligomers and protofibrils,
respectively [49]. Like the results described above and therefore in
line with our expectations, Ab(1–40) in the presence of Ca
2+ and
Ab(1–40)E22G both in the presence and in the absence of added
Ca
2+ all formed the same oligomeric species: initially spherical
particles, evolving to curvilinear structures after 72 h. These values
are consistent with the data from Mastrangelo et al. [55], where
the authors reported z-heights of 2–3 nm on average, for early
(,1 h) oligomers and ,2 nm for monomers of Ab(1–42) obtained
by high resolution AFM under hydrated conditions. Detailed
analysis of their results revealed that for low molecular weight
oligomers as well as protofibrils the z-height ranged between 2 to
4 nm. Only for some of the high molecular weight oligomers
Mastrangelo et al. reported values of z-height 4–6 nm. It is likely
that Ab(1–40) and Ab(1–42) do not form the same type of high
molecular weight oligomers and the growth of Ab(1–40) oligomers
might be restricted to the lateral dimension, without causing height
changes from monomers to oligomers.
In the presence of Ca
2+, the aggregation pathway of Ab(1–40)
was clearly shifted towards formation of oligomers, and not of
fibrils as occurred in the absence of added Ca
2+. Evidently,
therefore, the presence of calcium ions has a significant impact on
the aggregation process of Ab(1–40).
Discussion
The pathogenesis of Alzheimer’s disease is complex, and
involves marked molecular, cellular, and physiological changes.
Figure 3. ATR-FTIR spectra of Ab(1–40) and Ab(1–40)E22G. FTIR spectra of Ab(1–40) and Ab(1–40)E22G were taken in the presence and in the
absence of added Ca
2+, showing the amide I region of the spectra (1600–1700 cm
21). Aliquots of 2 ml were taken from each sample at t=0 ,2 ,6 ,2 4 ,
48, 72, and 96 h (shown in blue, green, red, cyan, purple, mustard, and dark blue, respectively). The data shown here were collected in one
continuous experiment and are representative of three independent trials.
doi:10.1371/journal.pone.0018250.g003
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2+ hypothesis, which introduced the concept of regulation
by Ca
2+ of neuronal death both in age-related and in pathogenic
processes, attempts to explain how disruptions in Ca
2+ homeostasis
that continue over a prolonged period are a proximate cause of
neurodegeneration in Alzheimer’s disease. Numerous studies have
linked Ab to Ca
2+ through demonstrating Ca
2+ up-regulation by
amyloid aggregates and relating Ca
2+ dysregulation to AD-causing
mutations. Accumulation of Ab aggregates has been shown to
initiate a complex pathological cascade, leading ultimately to
memory alterations, cognitive impairments, and neuronal death
[56]. Questions remain, however, concerning the role of early
preclinical processes that predate the pathology and may enable or
accelerate the aggregation of Ab, thereby contributing to
development of the disease. In particular, the possible contributory
effect of normal physiological changes that take place in old age is
still unknown.
In this work we tried to determine whether calcium can
facilitate the formation of oligomers that might in turn be held
responsible for neuronal toxicity. Using four different techniques,
we showed that Ab(1–40) forms oligomers and protofibrils in the
presence of 2 mM Ca
2+ similar to those produced by Ab(1–
40)E22G both in the presence and in the absence of added Ca
2+
(21 mM of calcium ion were present in ‘‘2Ca
2+ condition’’ buffer
due to their traces in MilliQ water and in HPLC-grade buffer). We
found that in the ‘‘2Ca
2+ condition’’ Ab(1–40) readily formed
fibrils, which were detectable by PAGE and by ThT fluorescence
analysis as well as by FTIR, and differences in secondary
structures were observed between oligomers and fibrils. Moreover,
Figure 4. Morphological comparison of Ab(1–40) and Ab(1–40)E22G. Contact mode AFM images (5 mm65 mm, Z scale 15 nm) of Ab(1–40)
and Ab(1–40)E22G peptides on mica, recorded either in phosphate buffer or in MOPS buffer with Ca
2+. Samples of Ab(1–40) and Ab(1–40)E22G in the
presence and absence of added Ca
2+ (marked as ‘‘+Ca
2+’’ or ‘‘2Ca
2+’’, respectively) at t=0, 6, or 72 h. Closer views (1 mm 61 mm, Z scale 15 nm) of
oligomers, protofibrils and fibrils are shown as insets in the panel of t=72 h (C, F, I, L). Images A, D, G, J were taken at t=0; images B, E, H, K were
taken at t=6 h. Peptide concentration was the same in all samples.
doi:10.1371/journal.pone.0018250.g004
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oligomers of Ab(1–40) and of Ab(1–40)E22G, all of which were
spherical or curvilinear in shape. Ab(1–40)E22G has been shown
to form oligomers and protofibrils in vivo and to cause early and
severe signs of AD in mice [57]. It remains an open question
whether the morphological similarity of oligomers of Ab(1–40)
formed in the presence of Ca
2+ to oligomers of Ab(1–40)E22G
formed also in the absence of added Ca
2+ implies that they have
similar toxic effects.
Previous studies of the role of Ca
2+ in Ab aggregation have
revealed acceleration of Ab(1–42) fibril formation in the presence
of Ca
2+ [58,59], but without acceleration in the kinetics of Ab(1–
40) fibrillization [59]. In the present study, however, we focused on
the role of Ca
2+ in the formation of oligomers, rather than in fibril
formation. Our experiments demonstrated that 2 mM Ca
2+
catalyze the formation of oligomers of Ab(1–40), whereas in the
absence of added Ca
2+ mostly fibrils were formed. To the best of
our knowledge, this is the first time that Ca
2+ has been shown to
induce Ab(1–40) to form oligomers. We conducted our present
experiments with 2 mM added CaCl2 and 100 mMA b.C a
2+
concentrations in the neuronal cytosol vary from hundreds of
nanomolars to micromolars, which is consistent with the
concentration of calcium traces in the ‘‘2Ca
2+ buffer’’. Higher
cytosolic calcium concentration may occur for prolonged periods
during slow after-polarization current of ER after Ca
2+ release
from intracellular stores during LTP induction [60]. The cytosolic
Ca
2+ load is an important factor in regulating the size of
mitochondrial Ca
2+ stores [60], and during neuronal activity,
which includes increases in cytosolic Ca
2+, mitochondria can take
up significant loads of Ca
2+ [61]. In addition, 2 mM Ca
2+ is close
to the concentration in the extracellular space, where formation of
oligomers may be initiated and from where they might
subsequently exert their toxic effect on the plasma membrane
[62,63]. Comparison of experiments carried out at 20 mm and
2 mM calcium suggests that extracellular calcium promotes
oligomerization of Ab(1–40). From additional information ob-
tained by measuring residual calcium in the ‘‘2Ca
2+’’ buffer it is
tempting to conclude that the intracellular concentration of
calcium does not promote oligomerization. It remains however,
that the intracellular Ab peptides and calcium concentrations are
difficult to evaluate and the existence of an intracellular effect can
not be rejected at this stage. Based on the previously published
data (as outlined in the Introduction) as well as our present
findings, we schematically summarize the potential effects of both
extra- and intracellular calcium ions on Ab and cells (Fig. 5).
To conclude, our results show that the formation of Ab(1–40)
oligomers is induced in the presence of 2 mM Ca
2+, whereas in the
presence of as little as 20 mMC a
2+ Ab(1–40) undergoes
fibrillogenesis. The mechanism of Ca
2+-induced Ab(1–40) aggre-
gation is currently under investigation. Nevertheless, the above
finding might constitute the missing link that connects early
dysregulation in Ca
2+ signaling to later onset of pathological and/
or cognitive symptoms characteristic of AD. In their recent review
focusing on intracellular Ab production and its assembly states,
LaFerla et al. [63] suggested that the buildup of intracellular Ab
might be an early event in the pathogenesis of AD as well as of
Down syndrome. Taking that notion further, we contemplate that
the early event in AD pathology might be the aggregation of
intracellular Ab in response to an increase in [Ca
2+]i as a result of
natural aging processes. These early aggregates could in turn exert
Figure 5. Potential interplay between Ab oligomers, Ca
2+, and a target cell in the initial stages of Alzheimer’s disease. (1) Age-related
increase in [Ca
2+]i promotes oligomerization of intracellular Ab. (2) Disruption of Ca
2+ homeostasis by oligomers, by either binding to or modulating
the activity of a number of receptors such as ryanodine (Ry) and inositol triphosphate (IP3R) [25]. (3) Increase in [Ca
2+]i. These three steps might form
an inimical cycle leading to increases in both cytosolic calcium and Ab oligomer concentrations. (4) Ab oligomers disrupt intracellular membranes,
leading to apoptosis [34,41,64]. (5) Extracellular calcium concentration ([Ca
2+]e) promotes oligomerization of extracellular Ab. (6) Oligomers form
nonspecific pores in the plasma membrane, disturbing cellular integrity and leading to apoptosis [65]. (7) Ab oligomers can interact and impair
calcium channels at the membrane surface, opening calcium importers and blocking calcium exporters such as the voltage-dependent calcium
channel [66]. Ab oligomers can affect surface expression of N-methyl-D-aspartate receptors (NMDARs) [67], may increase [68] or decrease the
conductance [69], and facilitate long-term synaptic depression by disrupting neuronal glutamate uptake [70].
doi:10.1371/journal.pone.0018250.g005
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PLoS ONE | www.plosone.org 8 March 2011 | Volume 6 | Issue 3 | e18250their toxic effect to alter Ca
2+ signaling, which may account for the
progressive decline in memory and the increase in neuronal cell
apoptosis that occurs during AD. This may constitute a possible
reason why in old age, when calcium imbalance is pronounced,
the probability of developing AD is increased. This may also offer
an alternative approach to prevention and treatment strategies for
this disease, targeting mechanistic causes rather than late-stage
symptoms.
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